John C. Vollmer
Known title: DirectorCIK: 0001723342
Associated companies
Transaction History
| AMTM | ▲ Buy | Option Exercise | 11,564 | — | 2/6/2026 | View on chart |
| AMTM | ▲ Buy | Grant | 5,062 | $0 | 2/6/2026 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 3,447 | — | 3/5/2025 | View on chart |
| AMTM | ▼ Sell | Other | 391,341 | — | 12/17/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade
Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade. Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.